349 results on '"Rommer P"'
Search Results
52. Reply to the 'Comment on 'Phase diagram of an impurity in the spin-1/2 chain: two channel Kondo effect versus Curie law''
53. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
54. Phase diagram of an impurity in the spin-1/2 chain: two channel Kondo effect versus Curie law
55. Spin- and charge-density oscillations in spin chains and quantum wires
56. Phase separation in t-J ladders
57. Impurity corrections to the thermodynamics in spin chains using a transfer-matrix DMRG method
58. A two-channel Kondo impurity in the spin-1/2 chain: Consequences for Knight shift experiments
59. Universal cross-over behavior of a magnetic impurity and consequences for doping in spin-1/2 chains
60. Serum neurofilament light chain withstands delayed freezing and repeated thawing
61. Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes
62. Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome
63. A class of ansatz wave functions for 1D spin systems and their relation to DMRG
64. Thermodynamic limit of the density matrix renormalization for the spin-1 Heisenberg chain
65. Immunological Aspects of Approved MS Therapeutics
66. Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
67. Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions
68. Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis.
69. Health-related quality of life in multiple sclerosis: temperament outweighs EDSS
70. As responsabilidades dos entes federados contratualizadas no âmbito de uma região de saúde
71. Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)
72. Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS
73. Effect of Methylprednisolone on Mammalian Neuronal Networks In Vitro
74. Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients
75. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
76. Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study
77. Longitudinal retinal optical coherence tomography in myelin oligodendrocyte glycoprotein antibody disorders
78. Biopsie bei tumorverdächtiger spinaler Raumforderung: Fallstrick Neuromyelitis optica
79. Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment—Past, Present, and Future Aspects
80. Metastasis of Hepatocellular and Renal Cell Carcinoma to the Hand
81. Rituximab for Secondary Progressive Multiple Sclerosis: A Case Series
82. Requirement for safety monitoring for approved multiple sclerosis therapies: an overview
83. CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders
84. Monoclonal antibodies in treatment of multiple sclerosis
85. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study
86. Lesion-Specific Metabolic Alterations in Relapsing-Remitting Multiple Sclerosis Via 7 T Magnetic Resonance Spectroscopic Imaging
87. Multipath QUIC for Access Traffic Steering Switching and Splitting in 5G Advanced
88. Monoclonal antibodies in the therapy of multiple sclerosis: An overview
89. Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
90. Bilateral spontaneous flexor digitorum profundus tendon rupture of the fifth digit: case report and literature review
91. Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis
92. Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis
93. Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Modelsand Multiple Sclerosis
94. Treatment Options in Multiple Sclerosis and Neuromyelitis Optica SpectrumDisorders
95. Das Mal de Debarquement Syndrom: Pathophysiologische Konzepte einer seltenen sensomotorischen Phantomempfindung und Fallbericht einer jungen Frau mit anhaltendem Schwankschwindel nach längerer Seefahrt
96. Supplementary Material for: Epidemiology of Multiple Sclerosis in Austria
97. Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
98. Rehabilitation von Patienten mit Rückenmarkstumoren
99. Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
100. First-line treatment with alemtuzumab for active multiple sclerosis: A nationwide post-marketing survey in Austria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.